Headache in Undergraduate Students and Biopsychosocial Status

September 30, 2023 updated by: şeyda öztürk

the Prevalance of Headache and Effects on Biopsychosocial Status in Undergraduate Students

The primary aim of this study was to determine the prevalence of headache in undergraduate students. The frequency, duration, localizations and symptoms of headache will be determined with the information obtained as a result of the forms filled in by the participants.

The second aim of this study is to examine the effects of headache on physical, social and psychological status in undergraduate student(participants) from a biopsychosocial perspective.

Study Overview

Detailed Description

Headache is one of the most common nervous system disorders in society. 95 percent of the population has experienced a headache at least once in their life. The one-year prevalence is almost 1 in 2 people.

The prevalence of headache increases with age. While there is no difference between the sexes in terms of incidence before adolescence, it is more common in the female population in the post-adolescent period.

The ICF model, developed by the World Health Organization, adopts the biopsychosocial approach to provide a holistic perspective. According to this approach, it is aimed to develop interventions by evaluating and examining the biological and psychosocial effects of illness and disability, functionality, needs and demands of the individual.

Headache is also a disease that should be addressed from a biopsychosocial perspective.

Therefore, the primary aim of this study was to determine the prevalence of headache in undergraduate students. The frequency, duration, localizations and symptoms of headache will be determined with the information obtained as a result of the forms filled in by the participants.

The second aim of this study is to examine the effects of headache on physical, social and psychological status in undergraduate student(participants) from a biopsychosocial perspective.

Study Type

Observational

Enrollment (Actual)

257

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey, 06000
        • Hacettepe Univercity

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

undergraduate students

Description

Inclusion Criteria:

  • Having undergraduate education at Hacettepe University Faculty of Physical Therapy and Rehabilitation.
  • be over 18 years old.
  • To know Turkish.
  • Volunteer to participate in the study.

Exclusion Criteria:

  • Being over 65 years old.
  • Having any neurological problem except headache.
  • Any additional problems that prevent him from completing the questionnaires and scales.

to be

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
undergraduate students
Hacettepe University Faculty of Physical Therapy and Rehabilitation undergraduate students
undergraduate student(participants) will be asked; age, weight, height, smoking and alcohol use, and headache.
ıd migraine test, numeric rate scale, hit-6 headache impact test, headache information form
hospital anxiety depression, Discomfort Intolerance Test, pittsburgh sleep quality index, fatigue severity scale, self compassion scale, Body Awareness Questionarre, cervical range of motion, İnternational Physical Activity Questionnaire, 12-Item Short-Form Health Survey

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
prevelance
Time Frame: april 2023-may 2023
Headache prevalence in undergraduate students
april 2023-may 2023

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
effect of headache on biopsychosocial status
Time Frame: april 2023-may 2023
Sleep Quality- Pittsburgh Sleep Quality Index- A minimum of 0 and a maximum of 21 points can be obtained from this scale. The higher the score, the worse the sleep quality.
april 2023-may 2023
effect of headache on biopsychosocial status
Time Frame: april 2023-may 2023
Anxiety Depression Level- Hospital Anxiety Depression Scale- A minimum of 0 and a maximum of 42 points can be obtained from this scale. The higher the score, the higher the severity of anxiety depression.
april 2023-may 2023
effect of headache on biopsychosocial status
Time Frame: april 2023-may 2023
Personal Information Form- In this form, participants' height, weight, age, gender, smoking and alcohol use, whether they have a headache or not, and their education level are questioned. there is no minimum or maximum value
april 2023-may 2023
effect of headache on biopsychosocial status
Time Frame: april 2023-may 2023
Self Compassion- Self Compassion Scale- A minimum of 24 and a maximum of 130 points can be obtained from this scale. The higher the score, the higher the level of self-compassion.
april 2023-may 2023
effect of headache on biopsychosocial status
Time Frame: april 2023-may 2023
Fatigue Level- The Fatigue Severity Scale - A minimum of 0 and a maximum of 9 points can be obtained from this scale. The higher the score, the higher the severity of fatigue.
april 2023-may 2023
effect of headache on biopsychosocial status
Time Frame: april 2023-may 2023
Body Awareness- Body Awareness Scale- A minimum of 18 and a maximum of 126 points can be obtained from this scale. The higher the score, the higher the body awareness.
april 2023-may 2023
effect of headache on biopsychosocial status
Time Frame: april 2023-may 2023
Physical Activity Level- International Physical Activity Questionnaire - The scale score is defined in 3 different categories as a result of the scores obtained in the range of minimum 0 and maximum +3000 points. As the score obtained from the scale increases, the level of physical activity increases. results are reported in categories. (low activity levels, moderate activity levels, or high activity levels).
april 2023-may 2023
effect of headache on biopsychosocial status
Time Frame: april 2023-may 2023
Cervical Range of Motion- The participant is asked to evaluate the cervical joint range of motion in 6 directions (flexion, extension, right/left lateral flexion, and right/left rotation). The minimum score is 0, the maximum score is 10. The higher the score, the higher the range of motion.
april 2023-may 2023
effect of headache on biopsychosocial status
Time Frame: april 2023-may 2023
Quality of Life-Short Form-12 (SF-12) - The total score ranges from 0-100. The higher the score, the higher the quality of life.
april 2023-may 2023
effect of headache on biopsychosocial status
Time Frame: april 2023-may 2023
Discomfort intolerance level- Discomfort Intolerance Scale- The total score changes from a minimum of 0 to a maximum of 42 points. As the total scores of the participants increase, it is accepted that the tolerance to the discomfort is higher.
april 2023-may 2023
effect of headache on biopsychosocial status
Time Frame: april 2023-may 2023
Numeric Rate Scale- A minimum of 0 and a maximum of 10 points is obtained from the scale. A high score indicates a high headache.
april 2023-may 2023
effect of headache on biopsychosocial status
Time Frame: april 2023-may 2023
ID- MIGRAINE TEST-There are 3 questions in this test. It is stated that the participants who answer yes to two of the questions are more likely to have migraine.
april 2023-may 2023
effect of headache on biopsychosocial status
Time Frame: april 2023-may 2023
Headache Impact Test (HIT-6™)- A minimum of 36 points and a maximum of 78 points are taken from this scale. The higher the total score obtained from the questionnaire, the worse the quality of life of the participants with headaches.
april 2023-may 2023
effect of headache on biopsychosocial status
Time Frame: april 2023-may 2023
In this form, participants with headaches are asked about the severity of the pain, the frequency, location and duration of the pain, whether there is a family history of headaches, etc.
april 2023-may 2023

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: nezire köse, prof, HacettepeUniversity Faculty of Physical Therapy and Rehabilitation

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 4, 2023

Primary Completion (Actual)

June 2, 2023

Study Completion (Actual)

June 12, 2023

Study Registration Dates

First Submitted

April 14, 2023

First Submitted That Met QC Criteria

May 2, 2023

First Posted (Actual)

May 6, 2023

Study Record Updates

Last Update Posted (Actual)

October 3, 2023

Last Update Submitted That Met QC Criteria

September 30, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Migraine

Clinical Trials on personal information form

Subscribe